Cargando…

Patient Health Questionnaire 9 (PHQ-9) and General Anxiety Disorder 7 (GAD-7) data contributed by 13,829 respondents to a national survey about COVID-19 restrictions in Australia

While the Patient Health Questionnaire 9 (PHQ-9) and General Anxiety Disorder 7 (GAD-7) are frequently used in mental health research, few studies have reported comprehensive data on these measures from population or community samples. The PHQ-9 and GAD-7 were used as indicators of symptoms of depre...

Descripción completa

Detalles Bibliográficos
Autores principales: Stocker, Ruby, Tran, Thach, Hammarberg, Karin, Nguyen, Hau, Rowe, Heather, Fisher, Jane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9754708/
https://www.ncbi.nlm.nih.gov/pubmed/33592399
http://dx.doi.org/10.1016/j.psychres.2021.113792
_version_ 1784851259781545984
author Stocker, Ruby
Tran, Thach
Hammarberg, Karin
Nguyen, Hau
Rowe, Heather
Fisher, Jane
author_facet Stocker, Ruby
Tran, Thach
Hammarberg, Karin
Nguyen, Hau
Rowe, Heather
Fisher, Jane
author_sort Stocker, Ruby
collection PubMed
description While the Patient Health Questionnaire 9 (PHQ-9) and General Anxiety Disorder 7 (GAD-7) are frequently used in mental health research, few studies have reported comprehensive data on these measures from population or community samples. The PHQ-9 and GAD-7 were used as indicators of symptoms of depression and anxiety in a national online anonymous survey to assess the mental health of adults in Australia during the COVID-19 restrictions. The aim of this study was to describe gender- and age-specific PHQ-9 and GAD-7 item and summary data contributed by those who completed this survey. Data were analysed descriptively. Complete survey responses were contributed by 13,829 people. For both measures, item-by-item results, summary statistics (mean, standard deviation, minimum, maximum, median and interquartile range) and prevalence of severity categories are reported for the whole sample, and disaggregated by gender and age groups. These comprehensive data provide a useful point of comparison for future COVID-19-related or other research among population or community samples. Other researchers are encouraged to report detailed PHQ-9 and GAD-7 data in the future, to enable and promote relevant between-group comparisons.
format Online
Article
Text
id pubmed-9754708
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-97547082022-12-16 Patient Health Questionnaire 9 (PHQ-9) and General Anxiety Disorder 7 (GAD-7) data contributed by 13,829 respondents to a national survey about COVID-19 restrictions in Australia Stocker, Ruby Tran, Thach Hammarberg, Karin Nguyen, Hau Rowe, Heather Fisher, Jane Psychiatry Res Article While the Patient Health Questionnaire 9 (PHQ-9) and General Anxiety Disorder 7 (GAD-7) are frequently used in mental health research, few studies have reported comprehensive data on these measures from population or community samples. The PHQ-9 and GAD-7 were used as indicators of symptoms of depression and anxiety in a national online anonymous survey to assess the mental health of adults in Australia during the COVID-19 restrictions. The aim of this study was to describe gender- and age-specific PHQ-9 and GAD-7 item and summary data contributed by those who completed this survey. Data were analysed descriptively. Complete survey responses were contributed by 13,829 people. For both measures, item-by-item results, summary statistics (mean, standard deviation, minimum, maximum, median and interquartile range) and prevalence of severity categories are reported for the whole sample, and disaggregated by gender and age groups. These comprehensive data provide a useful point of comparison for future COVID-19-related or other research among population or community samples. Other researchers are encouraged to report detailed PHQ-9 and GAD-7 data in the future, to enable and promote relevant between-group comparisons. Elsevier B.V. 2021-04 2021-02-08 /pmc/articles/PMC9754708/ /pubmed/33592399 http://dx.doi.org/10.1016/j.psychres.2021.113792 Text en © 2021 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Stocker, Ruby
Tran, Thach
Hammarberg, Karin
Nguyen, Hau
Rowe, Heather
Fisher, Jane
Patient Health Questionnaire 9 (PHQ-9) and General Anxiety Disorder 7 (GAD-7) data contributed by 13,829 respondents to a national survey about COVID-19 restrictions in Australia
title Patient Health Questionnaire 9 (PHQ-9) and General Anxiety Disorder 7 (GAD-7) data contributed by 13,829 respondents to a national survey about COVID-19 restrictions in Australia
title_full Patient Health Questionnaire 9 (PHQ-9) and General Anxiety Disorder 7 (GAD-7) data contributed by 13,829 respondents to a national survey about COVID-19 restrictions in Australia
title_fullStr Patient Health Questionnaire 9 (PHQ-9) and General Anxiety Disorder 7 (GAD-7) data contributed by 13,829 respondents to a national survey about COVID-19 restrictions in Australia
title_full_unstemmed Patient Health Questionnaire 9 (PHQ-9) and General Anxiety Disorder 7 (GAD-7) data contributed by 13,829 respondents to a national survey about COVID-19 restrictions in Australia
title_short Patient Health Questionnaire 9 (PHQ-9) and General Anxiety Disorder 7 (GAD-7) data contributed by 13,829 respondents to a national survey about COVID-19 restrictions in Australia
title_sort patient health questionnaire 9 (phq-9) and general anxiety disorder 7 (gad-7) data contributed by 13,829 respondents to a national survey about covid-19 restrictions in australia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9754708/
https://www.ncbi.nlm.nih.gov/pubmed/33592399
http://dx.doi.org/10.1016/j.psychres.2021.113792
work_keys_str_mv AT stockerruby patienthealthquestionnaire9phq9andgeneralanxietydisorder7gad7datacontributedby13829respondentstoanationalsurveyaboutcovid19restrictionsinaustralia
AT tranthach patienthealthquestionnaire9phq9andgeneralanxietydisorder7gad7datacontributedby13829respondentstoanationalsurveyaboutcovid19restrictionsinaustralia
AT hammarbergkarin patienthealthquestionnaire9phq9andgeneralanxietydisorder7gad7datacontributedby13829respondentstoanationalsurveyaboutcovid19restrictionsinaustralia
AT nguyenhau patienthealthquestionnaire9phq9andgeneralanxietydisorder7gad7datacontributedby13829respondentstoanationalsurveyaboutcovid19restrictionsinaustralia
AT roweheather patienthealthquestionnaire9phq9andgeneralanxietydisorder7gad7datacontributedby13829respondentstoanationalsurveyaboutcovid19restrictionsinaustralia
AT fisherjane patienthealthquestionnaire9phq9andgeneralanxietydisorder7gad7datacontributedby13829respondentstoanationalsurveyaboutcovid19restrictionsinaustralia